Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

366
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
366
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
134
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

250
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
250

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Automated Pharmacometric Model Development by Leveraging Low-Dimensional Neural ODEs and LASSO Regression.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

JAMA network open·2026
Same author

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Translational psychiatry·2026
Same author

Development and application of a CNS PBPK model that integrates CSF dynamics to optimize dosing regimens of antibacterial agents in pediatric patients with meningitis.

International journal of antimicrobial agents·2026
Same author

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia.

npj antimicrobials and resistance·2026
Same author

Brain activity as a candidate biomarker for personalised caffeine treatment in premature neonates.

Frontiers in pediatrics·2026

相关实验视频

Updated: Jun 30, 2025

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
10:42

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children

Published on: December 31, 2017

17.1K

基于药理动力学的儿科剂量评估和优化使用唾液 - 一个案例研究

Marion Anliker-Ort1, Frédérique Rodieux1,2, Victoria C Ziesenitz1,3

  • 1Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.

Journal of clinical pharmacology
|March 18, 2024
PubMed
概括
此摘要是机器生成的。

唾液采样可以通过减少对血样本的需求来简化儿科药理动力学 (PK) 研究. 虽然唾液对甲米醇代谢物的变异性比血更高,但它仍然可以帮助优化儿科药物剂量.

关键词:
孩子们的孩子们的孩子们的孩子们.婴儿 婴儿 婴儿 婴儿 婴儿甲胺醇的使用方法药物动力学 药物动力学药学指标 药学指标 药学指标这是唾液,唾液.

更多相关视频

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

849
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K

相关实验视频

Last Updated: Jun 30, 2025

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
10:42

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children

Published on: December 31, 2017

17.1K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

849
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K

科学领域:

  • 儿科药理学 儿科药理学
  • 药学指标 (Pharmacometrics) 是一个指标.
  • 药物新陈代谢 药物新陈代谢

背景情况:

  • 儿科用剂量需要了解药理动力学 (PK).
  • 儿童的血采样很困难,需要使用替代的PK采样策略.
  • 甲米醇是一种用于婴儿的非标签止痛药,需要PK评估.

研究的目的:

  • 评估唾液作为一种替代的PK矩阵,以简化儿科PK研究.
  • 为了研究唾液是否适合在婴儿中使用metamizole进行PK研究.
  • 评估减少血采样场景的可行性.

主要方法:

  • 进行了一项案例研究,涉及静脉注射甲米醇后的血和唾液PK样本采集.
  • 进行了活性代谢物4-甲基胺抗皮林 (4-MAA) 和4-氨基胺抗皮林 (4-AA) 的血/唾液药量计 (PMX) 建模.
  • 评估了使用PMX模拟的减少血采样场景.

主要成果:

  • 在血和唾液之间,甲米醇代谢物的分布很快.
  • 估计的平均唾液/血分数为4-MAA的0.32和4-AA的0.57.
  • 与血 (17%的4-MAA,11%的4-AA) 相比,唾液的残留变异性更高 (47%的4-MAA,28%的4-AA).
  • 一个简化的采样场景 (6唾液+1个血样本) 产生了类似于全血采样的PK参数估计.

结论:

  • 与血相比,唾液显示PK转化物的PK变异性增加,这限制了其在婴儿PK研究中作为唯一矩阵的使用.
  • 丰富的唾液采样可以减少用于PK表征所需的血样本的数量.
  • 这种方法促进了PK研究,以优化儿科药物剂量.